Issue 13, 2019, Issue in Progress
From the journal:

RSC Advances

Correction: Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapy

Ting Tang,ab   Xiao Sun,*c   Xuedong Xu,d   Yifeng Bian,a   Xiaojie Maa  and  Ning Chen*a  

* Corresponding authors

a Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China
E-mail: dentistchenning@126.com

b Department of Dental Implantology, Hefei Stomatology Hospital, Clinical School of Anhui Medical University, Hefei, China

c Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore 117585, Singapore
E-mail: xiaosun8000@163.com

d China Shijiazhuang Pharmaceutical Group Co., Ltd., Shijiazhuang, China

Abstract

Correction for ‘Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapy’ by Ting Tang et al., RSC Adv., 2019, 9, 2559–2566.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C9RA90017A
Article type
Correction
Submitted
25 Feb 2019
Accepted
25 Feb 2019
First published
05 Mar 2019
This article is Open Access
Creative Commons BY license

RSC Adv., 2019,9, 7277-7277

Permissions

Request permissions

Correction: Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapy

T. Tang, X. Sun, X. Xu, Y. Bian, X. Ma and N. Chen, RSC Adv., 2019, 9, 7277 DOI: 10.1039/C9RA90017A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements